✦ LIBER ✦

Advanced Healthcare Materials (Tiwari/Advanced) || Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease

✍ Scribed by Tiwari, Ashutosh

Book ID: 124061654
Publisher: John Wiley & Sons, Inc.
Year: 2014
Weight: 766 KB
Category: Article
ISBN: 1118773594
DOI: 10.1002/9781118774205.ch4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advanced Healthcare Materials (Tiwari/Ad

Advanced Healthcare Materials (Tiwari/Advanced) || Diagnosis and Treatment of Cancer-Where We are and Where We have to Go!

✍ Tiwari, Ashutosh 📂 Article 📅 2014 🏛 John Wiley & Sons, Inc. ⚖ 217 KB

Advanced Healthcare Materials (Tiwari/Ad

Advanced Healthcare Materials (Tiwari/Advanced) || Novel Biomaterials for Human Health: Hemocompatible Polymeric Micro-and Nanoparticles and Their Application in Biosensor

✍ Tiwari, Ashutosh 📂 Article 📅 2014 🏛 John Wiley & Sons, Inc. ⚖ 339 KB

Advanced Materials for Agriculture, Food

Advanced Materials for Agriculture, Food, and Environmental Safety (Tiwari/Advanced) || Potential Application of Nanoparticles as Antipathogens

✍ Tiwari, Ashutosh; Syväjärvi, Mikael 📂 Article 📅 2014 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 241 KB

DISCLOSURE OF DEMENTIA DIAGNOSIS AND THE

DISCLOSURE OF DEMENTIA DIAGNOSIS AND THE NEED FOR ADVANCE CARE PLANNING IN INDIVIDUALS WITH ALZHEIMER'S DISEASE

✍ Marja-Liisa Laakkonen; Minna M. Raivio; Ulla Eloniemi-Sulkava; Reijo S. Tilvis; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

[Advances in Pharmacology] Current State

[Advances in Pharmacology] Current State of Alzheimer's Disease Research and Therapeutics Volume 64 || Hsp90 Modulation for the Treatment of Alzheimer’s Disease

✍ Zhao, Huiping 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 489 KB

Sumanirole versus placebo or ropinirole

Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease

✍ Paolo Barone; Janice Lamb; Amanda Ellis; Zoe Clarke 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

## Abstract The aims of this study were to assess the safety, tolerability, and efficacy of sumanirole, a highly selective D~2~ dopamine receptor agonist, versus placebo in subjects with advanced Parkinson's disease (PD), and to demonstrate noninferiority of sumanirole to ropinirole. In this flexib